Status:
COMPLETED
Assessment of Asthma Control Level in Malaysia
Lead Sponsor:
AstraZeneca
Conditions:
Asthma Control Level
Eligibility:
FEMALE
Brief Summary
A Non-Interventional Retrospective Study To Assess The Level Of Asthma Control Among Adults at 2 Tertiary Care Centres In Malaysia; Institute Of Respiratory Medicine (IPR) And Hospital Serdang. The sp...
Detailed Description
Despite the availability of GINA global guideline on asthma management which is widely referred by health care providers in Malaysia, the control of asthma is still a critical challenge. According to ...
Eligibility Criteria
Inclusion
- All patients with GINA-defined clinical diagnosis of Asthma seen at respiratory clinic from January to August 2016.
- Be at least 18 years of age
Exclusion
- Clinical features suggesting emphysema or chronic bronchitis
- Other de-compensated organ failures
Key Trial Info
Start Date :
January 3 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 5 2017
Estimated Enrollment :
398 Patients enrolled
Trial Details
Trial ID
NCT03295331
Start Date
January 3 2017
End Date
April 5 2017
Last Update
May 11 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Perubatan Respiratori
Kuala Lumpur, Kuala Lumpur, Malaysia
2
Hospital Serdang
Kajang, Selangor, Malaysia